{"entity":{"type":"insider","cik":"0001430426","url":"/insider/0001430426","json_url":"/insider/0001430426.json","name":"IPPOLITO VINCENT P","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":7,"first":"2010-08-16","last":"2016-03-04","span_basis":"filed_date"},"name_variants":[{"name":"IPPOLITO VINCENT P","source":"filing","n_filings":7,"first_seen":"2010-08-16","last_seen":"2016-03-04"}],"transactions":[{"id":2412113,"accession":"0001209191-16-106294","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-106294","line_url":"/filing/0001209191-16-106294","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001430426","owner_name":"IPPOLITO VINCENT P","owner_display_name":"IPPOLITO VINCENT P","owner_url":"/insider/0001430426","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":63.8613973,"price_display":"63.86","price_state":"stated","total_value":574752.5757,"total_display":"574,752.58","total_whole":"574,753","shares_owned_after":69814.0,"shares_owned_after_display":"69,814","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-02","filed_date":"2016-03-04","scope":"insider","n_lines":4},{"id":2770439,"accession":"0001209191-16-092996","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-16-092996","line_url":"/filing/0001209191-16-092996","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001430426","owner_name":"IPPOLITO VINCENT P","owner_display_name":"IPPOLITO VINCENT P","owner_url":"/insider/0001430426","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":95.4102205,"price_display":"95.41","price_state":"stated","total_value":1908204.41,"total_display":"1,908,204.41","total_whole":"1,908,204","shares_owned_after":76485.0,"shares_owned_after_display":"76,485","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-19","filed_date":"2016-01-21","scope":"insider","n_lines":4},{"id":3253022,"accession":"0001209191-16-089486","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-089486","line_url":"/filing/0001209191-16-089486","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001430426","owner_name":"IPPOLITO VINCENT P","owner_display_name":"IPPOLITO VINCENT P","owner_url":"/insider/0001430426","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":855.0,"shares_display":"855","price_per_share":112.28277251461988,"price_display":"112.28","price_state":"stated","total_value":96001.7705,"total_display":"96,001.77","total_whole":"96,002","shares_owned_after":71185.0,"shares_owned_after_display":"71,185","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-04","filed_date":"2016-01-05","scope":"insider","n_lines":3},{"id":8420538,"accession":"0001209191-15-084824","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-084824","line_url":"/filing/0001209191-15-084824","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001430426","owner_name":"IPPOLITO VINCENT P","owner_display_name":"IPPOLITO VINCENT P","owner_url":"/insider/0001430426","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":107.90456345,"price_display":"107.90","price_state":"stated","total_value":2158091.269,"total_display":"2,158,091.27","total_whole":"2,158,091","shares_owned_after":74570.0,"shares_owned_after_display":"74,570","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-09","filed_date":"2015-12-11","scope":"insider","n_lines":2},{"id":8458519,"accession":"0001209191-15-022576","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-022576","line_url":"/filing/0001209191-15-022576","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001430426","owner_name":"IPPOLITO VINCENT P","owner_display_name":"IPPOLITO VINCENT P","owner_url":"/insider/0001430426","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":43.881847533333335,"price_display":"43.88","price_state":"stated","total_value":394936.6278,"total_display":"394,936.63","total_whole":"394,937","shares_owned_after":71757.0,"shares_owned_after_display":"71,757","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-03","filed_date":"2015-03-04","scope":"insider","n_lines":2},{"id":9066944,"accession":"0001246360-11-002526","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001246360-11-002526","line_url":"/filing/0001246360-11-002526#line-4","is_derivative":false,"issuer_cik":"0000859368","issuer_name":"MEDICIS PHARMACEUTICAL CORP","issuer_ticker":"MRX","issuer_name_source":null,"issuer_url":"/issuer/0000859368","owner_cik":"0001430426","owner_name":"IPPOLITO VINCENT P","owner_display_name":"IPPOLITO VINCENT P","owner_url":"/insider/0001430426","role":"Officer (EVP, Sales & Marketing)","role_mark":"O","role_mark_label":"Officer (EVP, Sales & Marketing)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Sales & Marketing","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":114356.0,"shares_display":"114,356","price_per_share":36.8752,"price_display":"36.88","price_state":"stated","total_value":4216900.3712,"total_display":"4,216,900.37","total_whole":"4,216,900","shares_owned_after":166270.0,"shares_owned_after_display":"166,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-13","filed_date":"2011-05-17","scope":"insider"},{"id":7735774,"accession":"0001246360-10-003035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001246360-10-003035","line_url":"/filing/0001246360-10-003035#line-1","is_derivative":false,"issuer_cik":"0000859368","issuer_name":"MEDICIS PHARMACEUTICAL CORP","issuer_ticker":"MRX","issuer_name_source":null,"issuer_url":"/issuer/0000859368","owner_cik":"0001430426","owner_name":"IPPOLITO VINCENT P","owner_display_name":"IPPOLITO VINCENT P","owner_url":"/insider/0001430426","role":"Officer (EVP, Sales & Marketing)","role_mark":"O","role_mark_label":"Officer (EVP, Sales & Marketing)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Sales & Marketing","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13012.0,"shares_display":"13,012","price_per_share":26.8959,"price_display":"26.90","price_state":"stated","total_value":349969.4508,"total_display":"349,969.45","total_whole":"349,969","shares_owned_after":152189.0,"shares_owned_after_display":"152,189","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-12","filed_date":"2010-08-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":17,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001411158","name":"Anacor Pharmaceuticals, Inc.","url":"/issuer/0001411158","role":"Officer (EVP & Chief Commercial Officer)","n_filings":5,"first_seen":"2015-03-04","last_seen":"2016-03-04"},{"type":"issuer","type_label":"ISSUER","cik":"0000859368","name":"MEDICIS PHARMACEUTICAL CORP","url":"/issuer/0000859368","role":"Officer (EVP, Sales & Marketing)","n_filings":2,"first_seen":"2010-08-16","last_seen":"2011-05-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001430426","retrieved_at":"2026-08-25T05:07:19+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}